The changing incidence and mortality of melanoma in Australia
- PMID: 12079205
- DOI: 10.1007/978-3-642-59410-6_15
The changing incidence and mortality of melanoma in Australia
Abstract
For many years Australia has had the highest incidence and mortality rates in the world for melanoma. The incidence rate has been increasing at around 5% per year and the mortality rate, at a rate slightly lower than that. Epidemiology studies have shown clearly that there is both a constitutional and an environmental contribution to melanoma risk, with sunlight being the major risk factor in the environment. The data also clearly show that the thickness of a melanoma at the time it is removed is one of the major determinants of the likelihood of metastasis and thus of the long-term prognosis. Both of these components have been incorporated into major public health programmes aimed at melanoma control in Australia over the last 25 years. Primary prevention programmes have been aimed at reducing the desire for a tan and subsequent overexposure to sunlight. Secondary prevention (early detection) programmes have encouraged people in the community to seek early attention if they notice a new or changing pigmented lesion. Although the age-adjusted incidence and mortality rates for Australia continue to rise, cohort analysis of both incidence and mortality rates reveals that the overall rise is not reflected in all age groups. In the younger cohorts--groups that it has been possible to influence by our public health campaigns in recent decades--both incidence and mortality rates are dropping.
Similar articles
-
Melanoma screening: Informing public health policy with quantitative modelling.PLoS One. 2017 Sep 25;12(9):e0182349. doi: 10.1371/journal.pone.0182349. eCollection 2017. PLoS One. 2017. PMID: 28945758 Free PMC article.
-
Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now?Australas J Dermatol. 1999 Feb;40(1):1-5. doi: 10.1046/j.1440-0960.1999.00307.x. Australas J Dermatol. 1999. PMID: 10098281 Review.
-
The Australian experience in sun protection and screening for melanoma.J Surg Oncol. 2004 Jul 1;86(4):236-45. doi: 10.1002/jso.20086. J Surg Oncol. 2004. PMID: 15221930
-
Epidemiology of Skin Cancer: Update 2019.Adv Exp Med Biol. 2020;1268:123-139. doi: 10.1007/978-3-030-46227-7_6. Adv Exp Med Biol. 2020. PMID: 32918216 Review.
-
Campaigning for melanoma prevention: a model for a health education program.J Eur Acad Dermatol Venereol. 2004 Jan;18(1):44-7. doi: 10.1111/j.1468-3083.2004.00802.x. J Eur Acad Dermatol Venereol. 2004. PMID: 14678530
Cited by
-
Measuring the health of nations: analysis of mortality amenable to health care.BMJ. 2003 Nov 15;327(7424):1129. doi: 10.1136/bmj.327.7424.1129. BMJ. 2003. PMID: 14615335 Free PMC article.
-
Cutaneous malignant melanoma in central iran: a 20-year study.Iran Red Crescent Med J. 2013 Aug;15(8):690-4. doi: 10.5812/ircmj.5364. Epub 2013 Aug 5. Iran Red Crescent Med J. 2013. PMID: 24578836 Free PMC article.
-
Comparing personal risk, melanoma knowledge and protective behaviour in people with and without melanoma: a postal survey to explore educational needs in northeast Scotland.J Cancer Educ. 2011 Jun;26(2):341-7. doi: 10.1007/s13187-010-0181-z. J Cancer Educ. 2011. PMID: 21161466 Clinical Trial.
-
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada.Dermatology. 2022;238(6):1006-1017. doi: 10.1159/000524949. Epub 2022 Jun 9. Dermatology. 2022. PMID: 35679838 Free PMC article.
-
Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure.Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):668-73. doi: 10.1073/pnas.0710615105. Epub 2008 Jan 7. Proc Natl Acad Sci U S A. 2008. PMID: 18180454 Free PMC article.
MeSH terms
LinkOut - more resources
Medical